14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.633 $1.34 Wednesday, 1st May 2024 VXRT stock ended at $0.701. This is 1.97% less than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 4.29% from a day low at $0.700 to a day high of $0.730.
90 days $0.633 $1.54
52 weeks $0.530 $1.59

Historical Vaxart prices

Date Open High Low Close Volume
Mar 26, 2024 $1.24 $1.25 $1.21 $1.22 798 353
Mar 25, 2024 $1.28 $1.28 $1.22 $1.23 2 282 675
Mar 22, 2024 $1.25 $1.28 $1.18 $1.26 1 799 216
Mar 21, 2024 $1.24 $1.27 $1.22 $1.23 1 181 840
Mar 20, 2024 $1.19 $1.25 $1.17 $1.24 1 475 010
Mar 19, 2024 $1.16 $1.29 $1.14 $1.16 2 910 397
Mar 18, 2024 $1.11 $1.16 $1.08 $1.16 1 150 131
Mar 15, 2024 $1.11 $1.16 $1.03 $1.08 2 035 406
Mar 14, 2024 $1.11 $1.13 $1.09 $1.10 1 171 955
Mar 13, 2024 $1.14 $1.17 $1.12 $1.13 987 992
Mar 12, 2024 $1.19 $1.19 $1.11 $1.14 1 011 821
Mar 11, 2024 $1.19 $1.25 $1.15 $1.15 1 398 279
Mar 08, 2024 $1.11 $1.21 $1.11 $1.19 1 788 141
Mar 07, 2024 $1.14 $1.20 $1.07 $1.11 2 077 572
Mar 06, 2024 $1.20 $1.24 $1.12 $1.20 1 326 951
Mar 05, 2024 $1.22 $1.24 $1.15 $1.21 1 296 619
Mar 04, 2024 $1.23 $1.26 $1.20 $1.23 1 194 995
Mar 01, 2024 $1.25 $1.26 $1.22 $1.25 1 505 988
Feb 29, 2024 $1.29 $1.31 $1.21 $1.22 1 182 485
Feb 28, 2024 $1.34 $1.34 $1.27 $1.30 1 265 085
Feb 27, 2024 $1.26 $1.29 $1.23 $1.27 1 354 716
Feb 26, 2024 $1.26 $1.28 $1.18 $1.23 1 899 624
Feb 23, 2024 $1.41 $1.43 $1.24 $1.27 2 345 526
Feb 22, 2024 $1.25 $1.54 $1.25 $1.40 4 435 047
Feb 21, 2024 $1.25 $1.45 $1.25 $1.41 5 296 880
Click to get the best stock tips daily for free!

About Vaxart

Vaxart Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the t... VXRT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT